Cargando…
L-Type Amino Acid Transporter 1-Utilizing Prodrugs of Ketoprofen Can Efficiently Reduce Brain Prostaglandin Levels
In order to efficiently combat neuroinflammation, it is essential to deliver the anti-inflammatory drugs to their target sites in the brain. Pro-drugs utilizing the L-type amino acid transporter 1 (LAT1) can be transported across the blood-brain barrier (BBB) and the cellular barriers of the brain’s...
Autores principales: | Montaser, Ahmed, Lehtonen, Marko, Gynther, Mikko, Huttunen, Kristiina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238114/ https://www.ncbi.nlm.nih.gov/pubmed/32290494 http://dx.doi.org/10.3390/pharmaceutics12040344 |
Ejemplares similares
-
l-Type Amino Acid Transporter 1 (LAT1/Lat1)-Utilizing Prodrugs Can Improve the Delivery of Drugs into Neurons, Astrocytes and Microglia
por: Huttunen, Johanna, et al.
Publicado: (2019) -
Sodium-Dependent Neutral Amino Acid Transporter 2
Can Serve as a Tertiary Carrier for l-Type Amino Acid
Transporter 1-Utilizing Prodrugs
por: Huttunen, Johanna, et al.
Publicado: (2023) -
Aminopeptidase B can bioconvert L-type amino acid transporter 1 (LAT1)-utilizing amide prodrugs in the brain
por: Hugele, Agathe, et al.
Publicado: (2022) -
L-Type amino acid transporter 1 as a target for drug delivery
por: Puris, Elena, et al.
Publicado: (2020) -
L-type
Amino Acid Transporter 1 Utilizing Ferulic
Acid Derivatives Show Increased Drug Delivery in the Mouse Pancreas
Along with Decreased Lipid Peroxidation and Prostaglandin Production
por: Tampio, Janne, et al.
Publicado: (2022)